Traws Pharma, Inc. (TRAW) Operating cash flow 2015–2024
Traws Pharma, Inc. (TRAW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$18.2MFY2024 · since FY2015: -$15.8M → -$18.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$18.2M | +39.0% |
| FY2023 | -$29.8M | -66.1% |
| FY2022 | -$17.9M | -10.1% |
| FY2021 | -$16.3M | +16.4% |
| FY2020 | -$19.5M | +15.5% |
| FY2019 | -$23.1M | -10.8% |
| FY2018 | -$20.8M | +8.2% |
| FY2017 | -$22.7M | +4.7% |
| FY2016 | -$23.8M | -50.6% |
| FY2015 | -$15.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TRAW financial trends
TRAW RevenueTRAW Net incomeTRAW Net marginTRAW Gross profitTRAW Gross marginTRAW Operating incomeTRAW Operating marginTRAW Free cash flowTRAW Capital expendituresTRAW Return on equityTRAW Stock buybacksTRAW Dividends paidTRAW Total assetsTRAW Total liabilitiesTRAW Shareholders’ equityTRAW overview →